Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
2024年12月19日 - 8:59PM
ビジネスワイヤ（英語）
Bristol Myers Squibb (NYSE: BMY) will announce results for the
fourth quarter of 2024 on Thursday, February 6, 2025. Company
executives will review financial results and address inquiries from
investors and analysts during a conference call beginning at 8:00
a.m. ET on the same date.
Investors and the general public are invited to listen to a live
webcast of the call at http://investor.bms.com. Investors and the
public can register for the live conference call here. Those unable
to register can access the live conference call by dialing in the
U.S. toll free 1-833-816-1116 or international +1 412-317-0705.
Materials related to the call will be available at
http://investor.bms.com prior to the start of the conference
call.
A replay of the webcast will be available at
http://investor.bms.com approximately three hours after the
conference call concludes. A replay of the conference call will be
available beginning at 11:30 a.m. ET on February 6, 2025, through
11:30 a.m. ET on February 20, 2025, by dialing in the U.S. toll
free 1-877-344-7529 or international +1 412-317-0088, conference
code: 5943651.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241219830221/en/
Media: media@bms.com
Investors: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
過去 株価チャート
から 11 2024 まで 12 2024
Bristol Myers Squibb (NYSE:BMY)
過去 株価チャート
から 12 2023 まで 12 2024
